QIAGEN 的 QIAstat-Dx 脑膜炎/脑炎试剂盒获得 FDA 批准，可用于快速诊断。 QIAGEN's QIAstat-Dx Meningitis/Encephalitis Panel receives FDA approval for rapid diagnosis.
QIAGEN已经获得林业发展局对QIAstat-Dx脑膜炎/脑炎小组的许可,这是2024年的第四次批准。 QIAGEN has gained FDA clearance for its QIAstat-Dx Meningitis/Encephalitis Panel, the fourth such approval in 2024. 这项检测有助于诊断严重疾病,如脑膜炎和脑炎,需要迅速治疗. This test aids in diagnosing serious conditions like meningitis and encephalitis, which require swift treatment. 该系统利用实时PCR技术,大约在一小时内提供结果,提高紧急诊断的速度和准确性。 Utilizing real-time PCR technology, the system provides results in about one hour, improving the speed and accuracy of emergency diagnostics. 这一批准反映了QIAGEN致力于加强其关键感染测试能力的承诺。 This approval reflects QIAGEN's commitment to enhancing its testing capabilities for critical infections.